S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Modern Day Options Trading For Beginners! (Ad)pixel
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
NASDAQ:OGI

Organigram - OGI Stock Forecast, Price & News

$0.63
-0.01 (-1.56%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.62
$0.65
50-Day Range
$0.60
$0.99
52-Week Range
$0.59
$1.87
Volume
267,956 shs
Average Volume
890,307 shs
Market Capitalization
$198.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.67

Organigram MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
163.4% Upside
$1.67 Price Target
Short Interest
Bearish
2.12% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.04) to ($0.03) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Medical Sector

815th out of 1,005 stocks

Pharmaceutical Preparations Industry

392nd out of 486 stocks


OGI stock logo

About Organigram (NASDAQ:OGI) Stock

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

OGI Stock News Headlines

Organigram Provides Edison JOLTS Product Update
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
OGI.TO - | Stock Price & Latest News | Reuters
Organigram Provides NASDAQ Listing Update
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Stocks in play: Organigram Holdings Inc.
Organigram Holdings Inc. Common Shares (OGI)
See More Headlines
Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

OGI Company Calendar

Last Earnings
1/12/2023
Today
3/26/2023
Next Earnings (Estimated)
4/11/2023
Fiscal Year End
8/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OGI
Fax
N/A
Employees
841
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.67
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+163.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-11,230,000.00
Pretax Margin
-5.41%

Debt

Sales & Book Value

Annual Sales
$111.27 million
Book Value
$1.27 per share

Miscellaneous

Free Float
313,656,000
Market Cap
$198.66 million
Optionable
Not Optionable
Beta
0.88

Key Executives

  • Beena G. Goldenberg
    Chief Executive Officer & Director
  • Nathalie Batten
    Vice President-Operations
  • Derrick W. West
    Chief Financial Officer
  • Geoff Riggs
    Chief Information Officer
  • Timothy Emberg
    Chief Revenue Officer













OGI Stock - Frequently Asked Questions

Should I buy or sell Organigram stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OGI shares.
View OGI analyst ratings
or view top-rated stocks.

What is Organigram's stock price forecast for 2023?

2 analysts have issued 1 year price targets for Organigram's shares. Their OGI share price forecasts range from $1.50 to $2.00. On average, they predict the company's share price to reach $1.67 in the next year. This suggests a possible upside of 163.4% from the stock's current price.
View analysts price targets for OGI
or view top-rated stocks among Wall Street analysts.

How have OGI shares performed in 2023?

Organigram's stock was trading at $0.80 on January 1st, 2023. Since then, OGI shares have decreased by 20.9% and is now trading at $0.6328.
View the best growth stocks for 2023 here
.

When is Organigram's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 11th 2023.
View our OGI earnings forecast
.

How were Organigram's earnings last quarter?

Organigram Holdings Inc. (NASDAQ:OGI) announced its earnings results on Thursday, January, 12th. The company reported ($0.01) EPS for the quarter, meeting analysts' consensus estimates of ($0.01). The firm earned $32.16 million during the quarter, compared to analyst estimates of $32.63 million. Organigram had a negative trailing twelve-month return on equity of 6.00% and a negative net margin of 4.97%.

What other stocks do shareholders of Organigram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

What is Organigram's stock symbol?

Organigram trades on the NASDAQ under the ticker symbol "OGI."

Who are Organigram's major shareholders?

Organigram's stock is owned by a number of institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (0.81%), Intact Investment Management Inc. (0.42%), Renaissance Technologies LLC (0.35%), Dimensional Fund Advisors LP (0.31%), Swiss National Bank (0.21%) and Baader Bank Aktiengesellschaft (0.18%).

How do I buy shares of Organigram?

Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Organigram's stock price today?

One share of OGI stock can currently be purchased for approximately $0.63.

How much money does Organigram make?

Organigram (NASDAQ:OGI) has a market capitalization of $198.66 million and generates $111.27 million in revenue each year. The company earns $-11,230,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis.

How many employees does Organigram have?

The company employs 841 workers across the globe.

How can I contact Organigram?

Organigram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for the company is www.organigram.ca. The company can be reached via phone at (844) 644-4726.

This page (NASDAQ:OGI) was last updated on 3/26/2023 by MarketBeat.com Staff